About Getwell Pharma
Getwell Pharma is a distinguished family-owned specialty pharmaceutical company that has been at the forefront of oncology drug manufacturing since 1985. With over 27 years of experience, we are committed to delivering the highest quality oncology products to more than 20 countries worldwide. Our expertise lies in the development and production of sterile oncology dosage forms, including liquid vials, lyophilized formulations, and complex novel drug delivery systems (NDDS).
Our journey began with a vision to provide affordable and high-quality pharmaceutical solutions, and over the years, we have evolved into India’s most reliable oncology manufacturer. Our dedicated team of over 250 professionals excels in research and development, ensuring that we remain at the cutting edge of innovation in oncology therapeutics.
At Getwell, we believe that better science leads to better life. Our commitment to excellence drives us to continuously improve our formulations and expand our capabilities, ensuring that we meet the diverse needs of patients and healthcare providers. We are proud to contribute to the fight against cancer through our robust pipeline of oncology drugs.
Why Choose Us?
Choosing Getwell Pharma means partnering with a leader in oncology pharmaceuticals. Here are several reasons why we stand out:
- Expertise: With decades of experience in oncology drug development, we specialize in creating effective and reliable cancer treatments.
- Quality Assurance: Our manufacturing processes adhere to the highest international standards, ensuring the safety and efficacy of our products.
- Innovative Solutions: We invest heavily in research and development, allowing us to pioneer advanced formulations that meet the evolving needs of the healthcare market.
- Global Reach: Our products are available in over 20 countries, making us a trusted partner for healthcare providers worldwide.
- Commitment to Affordability: We strive to provide high-quality oncology drugs at competitive prices, ensuring accessibility for all patients.